UA62007U - method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type - Google Patents

method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type

Info

Publication number
UA62007U
UA62007U UAU201100100U UAU201100100U UA62007U UA 62007 U UA62007 U UA 62007U UA U201100100 U UAU201100100 U UA U201100100U UA U201100100 U UAU201100100 U UA U201100100U UA 62007 U UA62007 U UA 62007U
Authority
UA
Ukraine
Prior art keywords
treatment
trimetazidine
patients
hypertrophic
evaluating
Prior art date
Application number
UAU201100100U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Михаил Васильевич Бычко
Ярослав Михайлович Бычка
Original Assignee
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет" filed Critical Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAU201100100U priority Critical patent/UA62007U/en
Publication of UA62007U publication Critical patent/UA62007U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for evaluating the effectiveness of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type with trimetazidine comprises the comparison of patients before and after treatment. Before treatment with trimetazidine in patients at rest the Doppler echocardiography is carried out and transmitral blood flow is determined by measuring the rate of early diastolic filling. After treatment with trimetazidine the similar study is performed.If the rate of early diastolic left ventricular filling is increased by 10.1% or more compared with the rate before treatment, the hemodynamic and antianginal effect results are evaluated as positive.
UAU201100100U 2011-01-04 2011-01-04 method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type UA62007U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201100100U UA62007U (en) 2011-01-04 2011-01-04 method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201100100U UA62007U (en) 2011-01-04 2011-01-04 method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type

Publications (1)

Publication Number Publication Date
UA62007U true UA62007U (en) 2011-08-10

Family

ID=50836434

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201100100U UA62007U (en) 2011-01-04 2011-01-04 method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type

Country Status (1)

Country Link
UA (1) UA62007U (en)

Similar Documents

Publication Publication Date Title
UA62007U (en) method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA61995U (en) method for evaluating the effectiveness of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle by "hypertrophic" type
UA59603U (en) method for evaluating the effectiveness of treatment with benidipin of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA59604U (en) method for evaluating the effectiveness of treatment with ISRADIPIN of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA59605U (en) method for evaluating the effectiveness of treatment with MANIDIPIN of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA61054U (en) method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA61052U (en) method for evaluating the effectiveness of treatment with quinapril of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA61981U (en) method for evaluating the effectiveness of treatment with clintiazem of patients with ischemia with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA78607U (en) method for evaluating the effectiveness of treatment with candesartan of patients with coronary heart disease with angina pectoris and hypertension at disorder of the left ventricular diastolic function by "hypertrophic" type
UA78612U (en) method for evaluating the effectiveness of treatment with losartan of patients with coronary heart disease with angina pectoris and hypertension at disorder of left ventricular diastolic function by "hypertrophic" type
UA61056U (en) method for evaluating the effectiveness of treatment with PERINDOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA71694U (en) Method for assessing efficacy of lovastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA64621U (en) method for estimation of efficiency of treatment of pregnant women with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type with PINDOLOL
UA95184C2 (en) Method for assesment of effectiveness of treatment WITH VERAPAMIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA95183C2 (en) Method for assesment of effectiveness of treatment WITH CILASAPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA91262U (en) Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA65049U (en) method for estimation of efficiency of treatment with TIMOLOL of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type
UA100785U (en) Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type
UA64628U (en) Method for assessing efficacy of celiprolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA91678U (en) Method for assessment of pitavastatin efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA64627U (en) Method for assessing efficacy of oxprenolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA56814U (en) Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
UA97337U (en) Method for evaluation the effectiveness of treatment with pepstatin in patients with coronary heart disease and angina and hypertension combined with bronchial asthma
UA55363U (en) Method for assessing efficacy of amlodipin in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
UA55362U (en) Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle